News

The Phase 2 trial tested whether inhibiting microglia with minocycline might help slow GA expansion and its corresponding vision loss.

Lonigutamab is a subcutaneously (SC) delivered humanized IgG1 monoclonal antibody targeting the insulin-like growth factor-1 receptor (IGF-1R).

Office-based surgery could prove to be a viable option for physicians.

Solar retinopathy is caused by prolonged or high intensity exposure of the fovea centralis to light energy. Suspected cases of solar retinopathy may require urgent referral to an ophthalmologist for diagnosis, and to eliminate treatable causes for central visual disturbance.

In court documents in Connecticut Superior Court in Bridgeport, Isidore Sobkowski claims surgeons at the Wilton Surgery Center failed to properly clean their instruments resulting in him contracting a sight-threatening eye infection.

According to the company, NCX 470 is a novel NO-donating bimatoprost eye drop, is currently in Phase 3 clinical development for the lowering of IOP in patients with open-angle glaucoma or ocular hypertension.

Electrophysiologic testing combined with structural imaging to zero in on issues.

NR1D1 and NR2E3 orphan nuclear receptors were found to have low levels of expression in patients with advanced retinoblastoma.

The company’s EVO family of Implantable Collamer Lenses for myopia, astigmatism and presbyopia, are designed to correct vision through a minimally invasive procedure.

Viewing the solar eclipse without proper eye protection can pose hazards, and ophthalmologists can educate patients about the importance of using certified solar viewing glasses or other safe viewing methods.

New members bring a wealth of experience and expertise from various sectors within the ophthalmology, pharmaceutical, and healthcare fields, further strengthening the Ophthalmology Foundation's mission.

Study findings show every $1 invested in eye care sees $36 in return globally

An investigation is set to launch on SpaceX’s 30th Commercial Resupply Services mission to the International Space Station contracted by NASA to test the therapy in space.

The benefit concert will be held at 8 pm April 7 at The Sinclair in Cambridge, and will feature performances by ophthalmologists and industry partners.

DMEI provides more than 225,000 total patient visits per year from all 77 Oklahoma counties and the surrounding six-state region through its main location on the University of Oklahoma Health Sciences Center campus in Oklahoma City and four satellite locations.

According to the foundation, the grants were awarded to 18 investigators at prominent universities in the United States, Nigeria, and Hong Kong.

Neda Shamie, MD, previews a collaborative day packed with guest speakers, discussions on advanced patient care, and hands-on labs.

According to the company, its Virtual Eye Pro features improve visual field testing for practice and patients.

The trial evaluated nesvategrast (OTT166 5%) eye drops in patients with diabetic retinopathy.

The reverse stock split is “part of the Company’s plan to regain compliance with the minimum bid price requirement for continued listing on The Nasdaq Capital Market."

Alexander Movshovich, MD, PhD, a specialist in keratopigmentation, sat down to talk about the controversy surrounding the procedure after it went viral on social media.

Patients who underwent LASIK had undergone phacoemulsification 7 years earlier compared to a matched control group, according to the study authors.

Even small changes can have a large impact, saving time for physicians.

Study demonstrates that patients achieved long-term visual acuity gains following CureSight treatment.

OCU410 is a modifier gene therapy candidate being developed for geographic atrophy, an advanced stage of dry age related macular degeneration.